WAYNE, PA — Palvella Therapeutics, Inc. (Nasdaq: PVLA) will mark a significant corporate milestone by ringing the opening bell at the Nasdaq Stock Market on Monday, May 12, 2025, in New York City. The ceremony, set to begin at approximately 9:15 a.m. ET, celebrates the company’s recent transition to a publicly traded entity on Nasdaq.
Wes Kaupinen, Founder and Chief Executive Officer, will lead the event alongside members of Palvella’s management team, Board of Directors, investors, advisors, and special guests.
“We are honored to have been invited by Nasdaq to participate in the opening bell ceremony and highlight Palvella’s vision to build the leading rare disease biopharmaceutical company serving individuals afflicted with serious, rare genetic skin diseases,” said Kaupinen.
The event spotlights Palvella’s effort to advance therapies for patients with rare genetic skin diseases, supported by its collaboration with investors, physicians, scientists, and patient advocacy groups. The milestone marks a pivotal moment in the company’s evolution and dedication to innovation in rare disease treatment.
Support the local news that supports Chester County. MyChesCo delivers reliable, fact-based reporting and essential community resources—free for everyone. If you value that, click here to become a patron today.